BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9758262)

  • 21. Intercellular adhesion molecule-1 (ICAM-1) in cervicovaginal fluid of women presenting with preterm labor: predictive value for preterm delivery.
    Marvin KW; Keelan JA; Coleman MA; McCowan LM; Zhou RL; Mitchell MD
    Am J Reprod Immunol; 2000 May; 43(5):264-71. PubMed ID: 10872605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Quantitative determination of fetal fibronectin in cervical smears: a new marker for evaluating the risk of premature labor].
    Hampl M; Friese K; Hofmann I; Melchert F
    Geburtshilfe Frauenheilkd; 1994 Dec; 54(12):685-90. PubMed ID: 7851710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the ability of cervical length and fetal fibronectin measurement to predict preterm delivery in asymptomatic women with risk factors.
    Zhou MX; Zhou J; Bao Y; Chen YQ; Cai C
    J Matern Fetal Neonatal Med; 2015 Jan; 28(2):153-7. PubMed ID: 24678648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cervicovaginal fetal fibronectin (FFN) for prediction of preterm delivery in symptomatic cases: a prospective study.
    Tanir HM; Sener T; Yildiz Z
    Clin Exp Obstet Gynecol; 2008; 35(1):61-4. PubMed ID: 18390084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The preterm prediction study: patterns of cervicovaginal fetal fibronectin as predictors of spontaneous preterm delivery. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network.
    Goldenberg RL; Mercer BM; Iams JD; Moawad AH; Meis PJ; Das A; McNellis D; Miodovnik M; Menard MK; Caritis SN; Thurnau GR; Bottoms SF
    Am J Obstet Gynecol; 1997 Jul; 177(1):8-12. PubMed ID: 9240575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low concentrations of vaginal fetal fibronectin as a predictor of deliveries occurring after 41 weeks.
    Lockwood CJ; Moscarelli RD; Wein R; Lynch L; Lapinski RH; Ghidini A
    Am J Obstet Gynecol; 1994 Jul; 171(1):1-4. PubMed ID: 8030682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of a quantitative fetal fibronectin test for spontaneous preterm birth in symptomatic women.
    Abbott DS; Radford SK; Seed PT; Tribe RM; Shennan AH
    Am J Obstet Gynecol; 2013 Feb; 208(2):122.e1-6. PubMed ID: 23164760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the Actim Partus test and the fetal fibronectin test in the prediction of spontaneous preterm birth in symptomatic women undergoing cervical length measurement.
    Bruijn MM; Vis JY; Wilms FF; Oudijk MA; Kwee A; Porath MM; Oei G; Scheepers HC; Spaanderman ME; Bloemenkamp KW; Haak MC; Bolte AC; Vandenbussche FP; Woiski MD; Bax CJ; Cornette JM; Duvekot JJ; Nij Bijvank BW; van Eyck J; Franssen MT; Sollie KM; van der Post JA; Bossuyt PM; Opmeer BC; Kok M; Mol BW; van Baaren GJ
    Eur J Obstet Gynecol Reprod Biol; 2016 Nov; 206():220-224. PubMed ID: 27750180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined fetal fibronectin and cervical length and spontaneous preterm birth in asymptomatic triplet pregnancies.
    Fox NS; Rebarber A; Roman AS; Klauser CK; Peress D; Saltzman DH
    J Matern Fetal Neonatal Med; 2012 Nov; 25(11):2308-11. PubMed ID: 22563765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Preterm Prediction Study: association between cervical interleukin 6 concentration and spontaneous preterm birth. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network.
    Goepfert AR; Goldenberg RL; Andrews WW; Hauth JC; Mercer B; Iams J; Meis P; Moawad A; Thom E; VanDorsten JP; Caritis SN; Thurnau G; Miodovnik M; Dombrowski M; Roberts J; McNellis D;
    Am J Obstet Gynecol; 2001 Feb; 184(3):483-8. PubMed ID: 11228507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Presence of fetal fibronectin in cervico-vaginal secretion as predictor of premature labor].
    García Alonso A; Ayala Méndez JA; Izquierdo Puente JC; Jiménez Solís G; Sánchez Martínez M
    Ginecol Obstet Mex; 1999 Jan; 67():23-8. PubMed ID: 10085606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of digital cervical examination on the expression of fetal fibronectin.
    McKenna DS; Chung K; Iams JD
    J Reprod Med; 1999 Sep; 44(9):796-800. PubMed ID: 10509304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cervical fetal fibronectin in patients at increased risk for preterm delivery.
    Bittar RE; Yamasaki AA; Sasaki S; Zugaib M
    Am J Obstet Gynecol; 1996 Jul; 175(1):178-81. PubMed ID: 8694047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fetal fibronectin testing and pregnancy outcomes among Texas Medicaid patients at risk for preterm birth.
    Barner JC; Petrilla AA; Kang HA; Shen X; Alshehri AM; Sullivan EM; Troeger KA; Richards KM; Blackwell SC
    Am J Manag Care; 2017 Dec; 23(19 Suppl):S363-S370. PubMed ID: 29297659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fetal fibronectin in patients at increased risk for premature birth.
    Nageotte MP; Casal D; Senyei AE
    Am J Obstet Gynecol; 1994 Jan; 170(1 Pt 1):20-5. PubMed ID: 8296822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contingent use of fetal fibronectin testing and cervical length measurement in women with preterm labour.
    Audibert F; Fortin S; Delvin E; Djemli A; Brunet S; Dubé J; Fraser WD
    J Obstet Gynaecol Can; 2010 Apr; 32(4):307-12. PubMed ID: 20500936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cervicovaginal interleukin-6 as a predictor of preterm birth in African American women.
    Woodworth A; Grenache DG; Gronowski AM
    Clin Chim Acta; 2011 May; 412(11-12):988-92. PubMed ID: 21300046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study.
    Shennan A; Crawshaw S; Briley A; Hawken J; Seed P; Jones G; Poston L
    BJOG; 2006 Jan; 113(1):65-74. PubMed ID: 16398774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fetal fibronectin versus cervical length as predictors of preterm birth in twin pregnancy with or without 17-hydroxyprogesterone caproate.
    Combs CA; Garite TJ; Maurel K; Das A;
    Am J Perinatol; 2014 Dec; 31(12):1023-30. PubMed ID: 24566755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cervicovaginal fetal fibronectin testing in threatened preterm labour--translating research findings into clinical practice.
    Chuileannain FN; Bell R; Brennecke S
    Aust N Z J Obstet Gynaecol; 1998 Nov; 38(4):399-402. PubMed ID: 9890218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.